Opthea Limited - ADR Stock, NASDAQ:OPT
650 Chapel Street, Suite 0403, South Yarra, Victoria (VIC) 3141
Number of Employees:
Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia.